Experimental and bioinformatics platform for epigenome analysis using nanopore sequencing

Information

  • Research Project
  • 10211967
  • ApplicationId
    10211967
  • Core Project Number
    R01GM136886
  • Full Project Number
    1R01GM136886-01A1
  • Serial Number
    136886
  • FOA Number
    PA-20-185
  • Sub Project Id
  • Project Start Date
    9/27/2021 - 4 years ago
  • Project End Date
    6/30/2025 - 11 months ago
  • Program Officer Name
    RAVICHANDRAN, VEERASAMY
  • Budget Start Date
    9/27/2021 - 4 years ago
  • Budget End Date
    6/30/2022 - 3 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    9/27/2021 - 4 years ago
Organizations

Experimental and bioinformatics platform for epigenome analysis using nanopore sequencing

PROJECT SUMMARY / ABSTRACT The epigenetic status of genomes including nucleosome occupancy, chromatin accessibility and DNA methylation, is highly relevant to the regulation of DNA-template biological processes from transcription to DNA replication and repair. Most existing techniques for characterizing epigenome utilize Next Generation Sequencing (NGS) following the biochemical reactions that capture the signals (e.g., bisulfite conversion, cross-linking and chromatin immunoprecipitation/ChIP). The development of these techniques has dramatically accelerated the research of different epigenetics events and has led to many important biological findings. As the new technique nanopore sequencing has been optimized to convey robust sequencing data of single DNA molecules with long read length, it brings in new discernible information that is useful for addressing certain challenging but important epigenetics problems. We develop an experimental protocol MeSMLR-seq and a series of bioinformatics methods to define the multiple types of epigenetic events, including nucleosome occupancy, chromatin accessibility and DNA methylation, at the rarely explored genome regions and biological context by leveraging the unique information of nanopore sequencing. Utilizing these experimental and bioinformatics methods, we aim to interrogate the following problems during the epigenetic reprogramming of early embryonic development and primordial germ cell development: in Aim 1, we will study the epigenetic regulation of transposable element expression and transposition. Aim 2 will construct the allele-specific epigenome and identify the genome loci with significant epigenome difference between alleles. Aim 3 will identify significant difference of the epigenomes between DNA strands and investigate their regulatory roles and dynamics during epigenetic reprogramming. These studies are anticipated to provide the first experimental and bioinformatics platform for improve our understanding of epigenome with complex biomedical context in a comprehensive manner.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R01
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
    300000
  • Indirect Cost Amount
    147440
  • Total Cost
    447440
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIGMS:447440\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    GCAT
  • Study Section Name
    Genomics, Computational Biology and Technology Study Section
  • Organization Name
    OHIO STATE UNIVERSITY
  • Organization Department
    MISCELLANEOUS
  • Organization DUNS
    832127323
  • Organization City
    COLUMBUS
  • Organization State
    OH
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    432101016
  • Organization District
    UNITED STATES